Here, PLK1 expression also positively correlated with CDK8, CDC25A, PLK4, and TOP2A (Supplementary Fig. 4), suggesting that these four gene targets may be of interest when considering PLK1 inhibition in ACC. The gene discussed is CDC25A; the disease is adrenal cortex carcinoma.